AP2008004711A0 - Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses - Google Patents

Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses

Info

Publication number
AP2008004711A0
AP2008004711A0 AP2008004711A AP2008004711A AP2008004711A0 AP 2008004711 A0 AP2008004711 A0 AP 2008004711A0 AP 2008004711 A AP2008004711 A AP 2008004711A AP 2008004711 A AP2008004711 A AP 2008004711A AP 2008004711 A0 AP2008004711 A0 AP 2008004711A0
Authority
AP
ARIPO
Prior art keywords
synthesis
therapeutic uses
molecules containing
peroxide derivative
dual molecules
Prior art date
Application number
AP2008004711A
Other languages
English (en)
Inventor
Bernard Meunier
Frederic Cosledan
Original Assignee
Sanofi Aventis
Centre Nat Rech Scient
Palumed Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37719816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2008004711(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis, Centre Nat Rech Scient, Palumed Sa filed Critical Sanofi Aventis
Publication of AP2008004711A0 publication Critical patent/AP2008004711A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AP2008004711A 2006-06-13 2007-06-08 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses AP2008004711A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0605235A FR2902100A1 (fr) 2006-06-13 2006-06-13 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
PCT/FR2007/000946 WO2007144487A2 (fr) 2006-06-13 2007-06-08 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
AP2008004711A0 true AP2008004711A0 (en) 2008-12-31

Family

ID=37719816

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004711A AP2008004711A0 (en) 2006-06-13 2007-06-08 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses

Country Status (24)

Country Link
US (1) US20120122923A1 (es)
EP (1) EP2032561A2 (es)
JP (1) JP2009539946A (es)
KR (1) KR20090029208A (es)
CN (1) CN101466706A (es)
AP (1) AP2008004711A0 (es)
AR (1) AR061347A1 (es)
AU (1) AU2007259116A1 (es)
BR (1) BRPI0713739A2 (es)
CA (1) CA2665940A1 (es)
CR (1) CR10469A (es)
EA (1) EA200970002A1 (es)
EC (1) ECSP088958A (es)
FR (1) FR2902100A1 (es)
IL (1) IL195394A0 (es)
MA (1) MA30577B1 (es)
MX (1) MX2008015980A (es)
NO (1) NO20085308L (es)
PE (1) PE20080335A1 (es)
TN (1) TNSN08462A1 (es)
TW (1) TW200817376A (es)
UY (1) UY30413A1 (es)
WO (1) WO2007144487A2 (es)
ZA (1) ZA200810012B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
BR112013022307A2 (pt) 2011-03-04 2020-09-24 Glaxosmithkline Intellectual Property (No. 2) Limited aminoquinolinas como inibidores de quinase
TWI547494B (zh) 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之胺基喹唑啉類
AR092530A1 (es) 2012-09-13 2015-04-22 Glaxosmithkline Llc Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
TWI592417B (zh) 2012-09-13 2017-07-21 葛蘭素史克智慧財產發展有限公司 胺基喹唑啉激酶抑制劑之前藥
RU2662810C2 (ru) 2013-02-21 2018-07-31 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Хиназолины в качестве ингибиторов киназы

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133620A1 (en) * 1993-10-28 1995-04-29 Werner Hofheinz Aminoquinoline derivatives
WO1997018193A1 (en) * 1995-11-16 1997-05-22 F. Hoffmann-La Roche Ag Antimalarial quinolin derivatives
US6320051B1 (en) * 1998-04-29 2001-11-20 Smithkline Beecham Plc Quinolones used as MRS inhibitors and bactericides
FR2807433B1 (fr) * 2000-04-06 2002-09-20 Centre Nat Rech Scient Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
WO2003070244A1 (en) * 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
SE0202134D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Therapeutic agents
AU2003288899B2 (en) * 2002-08-23 2009-09-03 Novartis Vaccines And Diagnostics, Inc. Benzimidazole quinolinones and uses thereof
US20050256157A1 (en) * 2002-08-23 2005-11-17 Chiron Corporation Combination therapy with CHK1 inhibitors
EP1464335A3 (en) * 2003-03-31 2007-05-09 Taisho Pharmaceutical Co. Ltd. Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
HU227684B1 (en) * 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
FR2862304A1 (fr) * 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
US20070185079A1 (en) * 2004-01-07 2007-08-09 Astrazeneca Ab Therapeutic agents I
US7884207B2 (en) * 2004-06-18 2011-02-08 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
FR2889525A1 (fr) * 2005-08-04 2007-02-09 Palumed Sa Nouveaux derives de polyquinoleines et leur utilisation therapeutique.

Also Published As

Publication number Publication date
AR061347A1 (es) 2008-08-20
MA30577B1 (fr) 2009-07-01
TW200817376A (en) 2008-04-16
EP2032561A2 (fr) 2009-03-11
TNSN08462A1 (en) 2010-04-14
IL195394A0 (en) 2009-08-03
EA200970002A1 (ru) 2009-06-30
BRPI0713739A2 (pt) 2013-06-18
CA2665940A1 (fr) 2007-12-21
JP2009539946A (ja) 2009-11-19
AU2007259116A8 (en) 2009-04-30
MX2008015980A (es) 2009-03-26
PE20080335A1 (es) 2008-05-22
ZA200810012B (en) 2010-05-26
FR2902100A1 (fr) 2007-12-14
UY30413A1 (es) 2008-01-31
KR20090029208A (ko) 2009-03-20
WO2007144487A3 (fr) 2008-02-07
NO20085308L (no) 2009-03-12
CN101466706A (zh) 2009-06-24
CR10469A (es) 2009-02-26
AU2007259116A1 (en) 2007-12-21
US20120122923A1 (en) 2012-05-17
ECSP088958A (es) 2009-01-30
WO2007144487A2 (fr) 2007-12-21

Similar Documents

Publication Publication Date Title
HK1246200A1 (zh) β-葡糖苷酸藥物連接子綴合物
EP1989185B8 (en) Therapeutic compounds
PL2087171T3 (pl) Produkt celulozowy
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
EP1929990A4 (en) DRUG DONATION
ZA201000185B (en) 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
GB0500643D0 (en) Medicaments
GB0621951D0 (en) Polynonomial synthesis
EP1981528A4 (en) COMBINED PRESSURE THERAPY
IL195394A0 (en) Dual molecules containing a peroxide derivatives, their synthesis and therapeutic uses
HK1136159A1 (en) Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
ZA201000187B (en) 17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP2010570B8 (en) Therapy against cathepsin s
GB0511204D0 (en) Medicaments
AP2010005307A0 (en) New therapeutic uses of dual molecules containing a peroxide derivative
GB0613031D0 (en) Medicaments
ZA201000186B (en) 17b-cyano-19-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP1853258A4 (en) DRUGS
PL2076521T3 (pl) Sposób otrzymywania sililopodstawionych 1,2 alkinów
AU2013257456A1 (en) Combination pressure therapy
AU2006905425A0 (en) Stabilised therapeutic molecules
AU2007906427A0 (en) Therapeutic molecules and their design and selection
SI2087171T1 (sl) Celulozni produkt
GB0608806D0 (en) Combination therapy product and uses thereof
AU2005905434A0 (en) Stabilised therapeutic molecules